Salona Global Medical Device Corporation (TSE:EVMT) has released an update.
Evome Medical Technologies Inc. has enhanced its financial position by selling its non-core Simbex unit, thus reducing acquisition debt and allowing a focus on the profitable Biodex product line, including the newly launched RST and upcoming SpaceTek Knee. Their strengthened relationship with Pathward, N.A. has facilitated continued innovation and market expansion. This strategic shift is aimed at boosting operational profitability and broadening their medical technology offerings.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
